Study of two anti-allergic drugs in allergic Conjunctivitis
Not Applicable
- Conditions
- Health Condition 1: null- Allergic Conjunctivitis
- Registration Number
- CTRI/2018/05/013792
- Lead Sponsor
- kempegowda institute of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a.Subjects aged >=18 years with clinical diagnosis of seasonal allergicconjunctivitis and perennial allergic conjunctivitis.
b.Willingness to give written informed consent and be available for regular follow-up visits.
Exclusion Criteria
a.Bacterial, viral or fungal conjunctivitis.
b.Subjects who have used topical or oral corticosteroids in the past two weeks.
c.Severe allergic conjunctivitis including vernal keratoconjunctivitis, atopic keratoconjunctivitis and giant papillary conjunctivitis.
d.History of severe dry eye.
e.History of ocular herpes.
f.Pregnant or lactating women.
g.Known hypersensitivity to the study drugs.
h.Subjects already taking the study drugs.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method